
X
Real-world data backs Kymriah’s safety profile, says Novartis
https://pharmaphorum.com/news/real-world-data-backs-kymriahs-safety-profile-says-novartis/
FDA granted full licence last year
Company successfully appealed against rejection last summer
Panel unanimously back CTL019
Pfizer locks horns with NICE following EU approval.
Drug will also be available to children via Cancer Drugs Fund.